Boothbay Fund Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.8K | Hold |
12,144
| – | – | ﹤0.01% | 1172 |
|
|
2025
Q1 | $41K | Sell |
12,144
-782
| -6% | -$2.64K | ﹤0.01% | 1128 |
|
|
2024
Q4 | $73.3K | Buy |
12,926
+691
| +6% | +$3.92K | ﹤0.01% | 1160 |
|
|
2024
Q3 | $71.6K | Hold |
12,235
| – | – | ﹤0.01% | 1288 |
|
|
2024
Q2 | $96.8K | Sell |
12,235
-27,382
| -69% | -$217K | ﹤0.01% | 1193 |
|
|
2024
Q1 | $369K | Sell |
39,617
-27,380
| -41% | -$255K | 0.01% | 979 |
|
|
2023
Q4 | $565K | Hold |
66,997
| – | – | 0.01% | 808 |
|
|
2023
Q3 | $519K | Buy |
66,997
+5,857
| +10% | +$45.4K | 0.01% | 850 |
|
|
2023
Q2 | $700K | Buy |
61,140
+49,324
| +417% | +$565K | 0.02% | 803 |
|
|
2023
Q1 | $91.1K | Sell |
11,816
-3,387
| -22% | -$26.1K | ﹤0.01% | 1712 |
|
|
2022
Q4 | $92.7K | Buy |
+15,203
| New | +$92.7K | ﹤0.01% | 1565 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 778 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 753 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 708 |
|